Allianz Asset Management GmbH - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is and the CUSIP is 04269XAB1. A total of 20 filers reported holding ARRAY BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q1 2019$14,606,000
+64.4%
8,300,000
+26.7%
0.01%
+55.6%
Q1 2018$8,887,000
-63.1%
6,550,000
-70.0%
0.01%
-52.6%
Q4 2017$24,057,00021,830,0000.02%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q1 2019
NameSharesValueWeighting ↓
Redmile Group, LLC 19,000,000$25,524,0000.87%
TENOR CAPITAL MANAGEMENT Co., L.P. 10,000,000$13,528,0000.81%
LINDEN ADVISORS LP 19,075,000$25,654,0000.79%
CSS LLC/IL 10,335,000$13,881,0000.65%
Graham Capital Management, L.P. 10,000,000$13,464,0000.50%
Verition Fund Management LLC 5,750,000$7,725,0000.47%
SG Americas Securities, LLC 120,000$16,121,0000.14%
WOLVERINE ASSET MANAGEMENT LLC 5,000,000$6,707,0000.09%
Nicholas Investment Partners, LP 500,000$670,0000.05%
DEUTSCHE BANK AG\ 31,370,000$42,065,0000.01%
View complete list of ARRAY BIOPHARMA INC shareholders